Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita1, Marie Henriksson
1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
Abstract:
Myc expression is deregulated in a wide range of human cancers and is often associated with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that regulates a variety of cellular processes including cell growth and proliferation, cell-cycle progression, transcription, differentiation, apoptosis, and cell motility. Potential strategies that either inhibit the growth promoting effect of Myc and/or activate its pro-apoptotic function are presently being explored. In this review, we give an overview of Myc activation in human tumors and discuss current strategies aimed at targeting Myc for cancer treatment. Such therapies could have potential in combination with mechanistically different cytotoxic drugs to combat and eradicate tumors cells.
Insights
Myc, a key protein in cancer, drives tumor growth and proliferation. Researchers are exploring new therapies to inhibit Myc
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Myc protein deregulation is common in human cancers.
- Myc overexpression correlates with aggressive, poorly differentiated tumors.
- Myc regulates critical cellular processes like growth, proliferation, and apoptosis.
Purpose of the Study:
- To review Myc activation in human tumors.
- To discuss current therapeutic strategies targeting Myc.
- To explore Myc's role in cancer treatment.
Main Methods:
- Literature review of Myc activation in cancer.
- Analysis of current and emerging Myc-targeting therapies.
- Discussion of combination strategies with cytotoxic drugs.
Main Results:
- Myc deregulation is a hallmark of various human cancers.
- Myc influences cell growth, proliferation, and apoptosis.
- Targeting Myc presents a promising avenue for cancer therapy.
Conclusions:
- Myc is a significant therapeutic target in oncology.
- Inhibiting Myc's growth-promoting effects or activating its pro-apoptotic functions are key strategies.
- Combination therapies involving Myc inhibitors may enhance tumor eradication.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
07:46In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...